diclofenac has been researched along with Corneal Angiogenesis in 2 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Shi, H | 1 |
Zhu, Y | 1 |
Xing, C | 1 |
Li, S | 1 |
Bao, Z | 1 |
Lei, L | 1 |
Lin, D | 1 |
Wang, Y | 1 |
Chen, H | 1 |
Xu, X | 1 |
Dana, MR | 1 |
Streilein, JW | 1 |
2 other studies available for diclofenac and Corneal Angiogenesis
Article | Year |
---|---|
An injectable thermosensitive hydrogel for dual delivery of diclofenac and AvastinĀ® to effectively suppress inflammatory corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Biocompatible Materials; Corneal Neovascularization; | 2022 |
Loss and restoration of immune privilege in eyes with corneal neovascularization.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cornea | 1996 |